The Solid Tumour Program is a relatively recent entity within SAHMRI’s Precision Medicine theme. The institute’s former Cancer Program has evolved into two specialty programs focused on solid tumours and blood cancers.

This program primarily investigates ways to better diagnose and treat multiple myeloma and cancers of the gut and prostate, but also contains groups that look to realise the potential of mesenchymal stem cells and that pursue better ways to support people undergoing cancer treatment.